This inventor holds 21 USPTO granted patents, primarily in Heterocyclic Chemistry. Top assignees: Sanofi, Sanofi-Synthelabo, Elf Sanofi. Active years: 1993-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- La Croix-Sasgarde, FR (1997 - 1998)
- Lacroix, FR (1993 - 2000)
- Lacroix Falgarde, FR (1995 - 2000)
- Lacroix-Falguarde, FR (2000)
- Paris, FR (2012 - 2013)
Company Filing History:
Years Active: 1993-2013
Areas of Expertise:
Title: Innovations and Contributions of Gerard Valette in Pharmaceutical Patents
Introduction
Gerard Valette, an accomplished inventor based in Lacroix Falgarde, France, has made significant contributions to the field of pharmaceuticals with his innovative inventions. With a portfolio of 21 patents, he has focused his research on the development of novel therapeutic compounds.
Latest Patents
Among his latest patents is the invention of 3-aminoalkyl-1,3-dihydro-2H-indol-2-one derivatives, which details their preparation and therapeutic applications. These compounds exhibit a strong affinity and high selectivity for human arginine-vasopressin (AVP) Vreceptors. The inventive compounds align with the following formula (I), where the variables are defined as stated in the specification, showcasing their potential for targeted therapeutic use.
Career Highlights
Gerard Valette has had a distinguished career, with significant tenures at renowned pharmaceutical companies such as Sanofi and Sanofi-Synthelabo. His work has been pivotal in advancing drug development and therapeutic options in the medical field.
Collaborations
Throughout his career, Gerard has collaborated with industry professionals such as Loic Foulon and Georges Garcia, further enhancing innovation and expertise within his projects. These collaborations have fostered an environment of creativity, leading to the attainment of numerous patents and advancements in pharmacology.
Conclusion
Gerard Valette's innovative spirit and expertise in pharmaceuticals have resulted in groundbreaking patents that contribute to therapeutic advancements. His commitment to research and collaboration highlights the importance of inventors in driving progress within the medical community. As an esteemed inventor, Valette continues to influence the field with his substantial contributions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile